The cells from approximately 70% patients with acute myeloapoptosis: these molecules do not prevent drug-induced cell blastic leukaemia exhibit autonomous growth characteristics in damage and cell cycle arrest, but reduce the rate of subvitro, which have been associated with a poor response to thersequent cell death. [7] [8][9] apy. We have previously shown that leukaemic cells with
Blood or bone marrow samples were obtained at diagnosis from 12 patients with de novo AML and two patients with transformed CML, and from one patient with relapsed AML.
Introduction
The diagnosis of AML was made using FAB criteria following conventional cytochemical stains and surface marker analysis. Clonogenic cells from a majority of patients with acute myeMononuclear cells were separated using density gradient seploblastic leukaemia (AML) have the capacity to proliferate aration (Histopaque; Sigma, Poole, UK), and were cryoprespontaneously in semi-solid methyl cellulose culture. 1 Cells served in 10% dimethyl sulphoxide and 20% FCS in liquid which exhibit these autonomous growth characteristics are nitrogen. Viability of cells thawed following cryopreservation able to survive for up to several weeks in suspension culture was routinely Ͼ90%. in the absence of exogenous growth factors, whereas cells with non-autonomous growth characteristics undergo apoptosis within a few days. 2 We have previously shown that Staining with antibodies for flow cytometry cells with autonomous growth characteristics express significantly higher levels of the anti-apoptotic protein bcl-2, comCells were quickly thawed and rinsed twice in cold RPMI pared to cells which do not grow autonomously in culture. 2 1640 containing 10% FCS and 1% v/v preservative-free hepFurthermore, patients whose cells exhibit autonomous growth arin. The primary antibodies used were S-18 anti-bcl-x (Santa have a significantly inferior complete remission rate and overCruz Biotechnology, Santa Cruz, CA, USA), MRK16 anti-Pall survival. 3, 4 gp (Kamiya Biomedical, Tukwila, WA, USA), MRPr1 anti-MRP The programme of cell death by apoptosis can be positively (Monosan, Uden, The Netherlands) and FITC-conjugated antior negatively regulated by other members of the bcl-2 family CD34 (Dako, Glostrup, Denmark). Cells for CD34 and P-gp including bcl-x (reviewed in Ref. 5 ). Due to a differential splicmeasurement were resuspended in PBS containing 1% bovine ing mechanism the bcl-x gene encodes for bcl-x L , an apoptosis serum albumin and 0.1% sodium azide (PBSAA). Cells for bclsuppressor and for bcl-x S , an inhibitor of bcl-2 function.
6 Both x measurement were fixed and permeabilised in 35% ethanol bcl-2 and bcl-x L confer resistance to cytotoxic drug-induced for 10 min, rinsed twice in PBSAA and resuspended in the same buffer. MRP was measured on cells fixed for 10 min in lysing solution from Becton Dickinson (Oxford, UK), rinsed twice in PBSAA and resuspended in the same buffer. 16 All pro- temperature, and all primary antibodies were added to 2 × 10 5
Cultures were plated in triplicate. Autonomous growth of AML blasts was assessed by their ability to form colonies within 5-cells in 100 l buffer for 30 min. Bcl-x was measured using 10 l polyclonal rabbit antibody S-18 followed by three rinses 7 days of culture in the absence of 5637 CM as contrasted with colonies which grew only in the presence of 5637 CM. 1, 2 in PBSAA. Nonspecific binding sites were blocked for 30 min with 20% normal swine serum in PBSAA. The cells were labelled using one in 25 FITC-conjugated swine anti-rabbit Igs (Dako) followed by three further rinses. Normal rabbit Immunoblotting immunoglobulins (Dako) diluted to the same protein concentration as the primary antibody were used as negative control. The protein concentration of AML blasts lysed in SDS detergent buffer was determined using the Bio-Rad (Hemel P-gp was measured using 2 l of the IgG2a monoclonal antibody MRK16. Following three rinses and blocking with 20%
Hempstead, UK) protein assay system. Twenty micrograms protein per well was loaded onto 15% polyacrylamide gels normal rabbit serum, the cells were labelled with one in 25 FITC-conjugated rabbit-anti-mouse Igs (Dako) for 30 min and (Bio-Rad minigel), separated using 200 V for 35 min and transferred to nitrocellulose membranes using 100 V for 1 h. The rinsed three times in PBSAA. A concentration-matched IgG2a antibody was used as control. MRP was measured using 10 l membranes were blocked overnight at 4°C in Tris-buffered saline containing 0.1% Tween 20 and 5% dried milk and proof the rat IgG2a monoclonal antibody MRPr1 and a rat IgG2a concentration-matched negative control (Caltag, San Francibed with 0.5 g/ml S-18 anti-bcl-x in the same buffer for 1 h at room temperature. The blots were then washed three times, sco, CA, USA), rinsed and blocked as above and was detected with one in 250 FITC-conjugated rabbit anti-rat immunogloblabelled in one in 13 000 horseradish peroxidase conjugated anti-rabbit antibody (Sigma) for 1 h at room temperature, ulins (Sigma).
For dual-staining experiments, cells were fixed in 1% parwashed three times and visualised using the Amersham enhanced chemiluminescence detection system. aformaldehyde, blocked with normal mouse serum and incubated with anti-CD34-PE (HPCA-2; Becton Dickinson). After rinsing, the cells were permeabilised with saponin, and stained for bcl-x as above.
Statistics
Pearson correlation coefficients and the Mann-Whitney U test were performed using SPSS software.
Flow cytometry
Fluorescence was measured using a FACScan (Becton Dickinson) at a constant FL1 setting (537 V). Measurements Results were standardised by regular use of polystyrene beads with stable fluorescence (Quantum 26; Flow Cytometry Standards, Validation of quantitative flow cytometric methodology for bcl-x Leiden, The Netherlands). The number of bound FITC molecules corresponding to the fluorescence of these beads had been previously calibrated using a 125 I/FITC dual-labelled antiIn order to quantify and compare the fluorescence of cells labelled with the polyclonal anti-bcl-x antibody S18, cells body system. 17 Five thousand events were collected using Consort 30 software and analysed using Lysis. Blast cells were from three patients were repeatedly thawed and processed in an identical manner for flow cytometry (as described in selected on the basis of forward and side-scatter characteristics. For quantitative analysis, the channel number correMaterials and methods). In two patients with higher expression of bcl-x, the coefficients of variation were 10.2 and sponding to the 90th percentile fluorescence on test histograms was determined as a sensitive measure of increased 11.9% (Table 1) . A higher coefficient of variation, 32%, was obtained in a patient with comparatively low bcl-x expression. fluorescence which may be occurring on a subset of cells.
18
Channel numbers were converted to molecules of bound FITC using Quickcal software (Flow Cytometry Standards). Control values were subtracted from test values.
Expression of bcl-x in patients with AML
Using quantitative flow cytometry, with concentrationmatched nonspecific rabbit immunoglobulins as a negative AML blast cell colony assay control, all 15 patients in the study were found to express bclx. Bcl-x expression appeared homogeneous in each sample This has been described previously. 2 Briefly, fresh cells were cultured at 2 × 10 4 cells/well in Iscove's modified Dulbecco's ( Figure 1 ) and ranged from 0.25 × 10 5 to 4.24 × 10 5 bound FITC molecules, (median 1.35 × 10 5 ). The S18 antibody recogmedium containing 10% FCS and 0.8% methyl cellulose in 100 l volumes in the presence and absence of medium connises an epitope common to the long and short forms of bclx, and immunoblotting was therefore used to distinguish ditioned by the 5637 bladder carcinoma cell line (5637 CM). Bcl-x expression and autonomous growth in vitro
We have previously shown that cells from approximately 68% patients with AML will grow in vitro without the need for added growth factors. 1, 4 In the current study, seven samples with AML (patient 10 in Table 2 ) with unfilled histogram representing growth ( Table 2) to apoptosis and express higher levels of bcl-2 than AML blasts with nonautonomous growth characteristics, 2 we were interested in analysing the relationship between growth characteristics and bcl-x L expression. As shown in Figure 2 and Table 2 , AML blasts with autonomous growth expressed significantly higher levels of bcl-x L (median 1.76 × 10 5 ) than those with nonautonomous growth (median 0.86 × 10 5 , P = 0.01, MannWhitney U-test).
Relative expression of bcl-x and multidrug resistance proteins
To study the relationship between the expression of bcl-x L and P-glycoprotein, we used quantitative flow cytometry to measure the number of MRK16-associated FITC molecules per cell (as described in Materials and methods). Bcl-x L and P-gp expression were found to be closely correlated (r = 0.95, P Ͻ 0.001, see Figure 3 ). MRPr1 expression was elevated in two of 16 patients (AML11 and AML18 in Table 2 ). However there was no correlation between bcl-x and MRPr1 (P = 0.15). and bcl-x expression has been demonstrated on CD34 + early haematopoietic progenitor cells. 20 We therefore examined the association of CD34 and bcl-x in AML blasts. CD34 expression was analysed in two ways. The percentage of positive cells was calculated on histograms gated at the channel where 1% of the negative control fell in the positive range. The channel corresponding to 90th percentile fluorescence was also recorded. Neither of these parameters correlated significantly with bcl-x expression (P = 0.18 for percentage data, P = 0.35 for 90th centile data). Flow cytometric data obtained by double labelling cells from four patients with CD34 indicated that CD34-positive cells tend to express comparable levels of bcl-x to CD34-negative cells in the same patient sample (Figure 4 ).
Discussion
The bcl-x gene codes for two proteins with opposing effects on apoptosis: the bcl-x L transcript encodes for a protein which suppresses apoptosis at least as effectively as bcl-2, whereas bcl-x S antagonises bcl-2 function. 6 Bcl-x L has been detected in myeloid leukaemic cell lines, 21 but its expression has not previously been studied in primary AML cells. Here we report that, using immunoblotting, bcl-x L is detectable in all cases of adult AML, whereas the pro-apoptotic form bcl-x S was not detected in any of the 16 samples.
Bcl-x protein was quantified by flow cytometry using a polyclonal antibody S-18. Polyclonal antibodies are not com- the dilution used, and that therefore the more consistent binding of higher affinity antibodies predominates. The results of the flow cytometric quantitation of bcl-x bcl-x L . We have previously demonstrated that cells with autonomous growth characteristics, ie cells which grow in showed considerable variation with a 15-fold range of antigen density. From the immunoblotting results we are assured that culture without added growth factors, are resistant to the induction of apoptosis; furthermore, we and others have this reflected heterogeneity in bcl-x L expression. The expression of bcl-x L was found to be significantly related to shown that such cells express high levels of bcl-2. exposed to cytotoxic drugs, suggesting that overexpression of 473-476. bcl-x L may be an important mechanism of acquired drug bcl-x L .
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